Search results for " DELIVERY"

showing 10 items of 1045 documents

Testing the Modified Sediment Delivery Model (MOSEDD) at SPA2 Experimental Basin, Sicily (Italy)

2017

A new version of a spatially distributed sediment delivery model taking into account the hillslope sediment transport efficiency, named MOSEDD, is presented. This model gives estimates of basin sediment yield at event scale, which are more reliable than those obtained by the original SEDD. For SPA2 basin discretized into morphological units, four different calculation schemes of MOSEDD, including the original SEDD version, were applied. All parameterization schemes of the model were calibrated using 15 events measured at the outlet of the experimental basin in the period February 2005–February 2010. The model calibration was used to determine a relationship between the coefficient βe of the…

sediment deliveryMOSEDDsoil erosion2300experimental basinEnvironmental ChemistrySoil ScienceSettore AGR/08 - Idraulica Agraria E Sistemazioni Idraulico-Forestalidistributed modelDevelopment3304 Education
researchProduct

Delivery of shNupr1 plasmid by solid lipid nanoparticles reduces the expression of Nupr1 gene in hepatocellular carcinoma cells

2015

shNupr1 plasmid gene delivery hepatocellular carcinoma
researchProduct

Polymeric nanoparticles for siRNA delivery: Production and applications

2017

Gene therapy through the use of siRNA and a polymeric carrier are becoming an efficient therapeutic option to conventional pharmaceutical formulations for the treatment of deadly diseases, such as cancer, pulmonary, ocular and neurodegenerative diseases. However, several considerations regarding the stability, formulation, and efficacy have to be faced up until these systems could be considered to be a marketable pharmaceutical products for to extend siRNA application to clinical practice. This review is focused on the key challenges of siRNA therapeutics, with special attention on the faced obstacles and on the formulation-related difficulties, providing a list of requirements needed for o…

siRNA deliveryPolymersPharmaceutical ScienceNanotechnology02 engineering and technologyPolyethylenimine010402 general chemistry01 natural scienceschemistry.chemical_compoundPolyaminesHumansRNA Small InterferingPolyethylenimineChitosanPolymeric non viral vectorInulinChitosan; Inulin; Polyaspartamide; Polyethylenimine; Polymeric non viral vectors; siRNA delivery.Genetic Therapy021001 nanoscience & nanotechnologyPolymeric nanoparticles0104 chemical sciencesClinical PracticePolyaspartamidechemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoPolymeric non viral vectorsNanoparticles0210 nano-technologyPeptidessiRNA delivery.
researchProduct

Development of New Targeted Inulin Complex Nanoaggregates for siRNA Delivery in Antitumor Therapy.

2021

Here, a novel strategy of formulating efficient polymeric carriers based on the already described INU-IMI-DETA for gene material whose structural, functional, and biological properties can be modulated and improved was successfully investigated. In particular, two novel derivatives of INU-IMI-DETA graft copolymer were synthesized by chemical functionalisation with epidermal growth factor (EGF) or polyethylenglycol (PEG), named INU-IMI-DETA-EGF and INU-IMI-DETA-PEG, respectively, in order to improve the performance of already described “inulin complex nanoaggregates” (ICONs). The latter were thus prepared by appropriately mixing the two copolymers, by varying each component from 0 to 100 wt%…

siRNA deliveryRNase PCellPharmaceutical Science02 engineering and technology010402 general chemistry01 natural sciencesArticleAnalytical Chemistrylcsh:QD241-441EGF; inulin; PEG; siRNA delivery; targeting; tumourlcsh:Organic chemistryEpidermal growth factorNeoplasmsDrug DiscoveryPEG ratioZeta potentialmedicineCopolymerHumansDoxorubicinPhysical and Theoretical ChemistryRNA Small InterferingtargetingEGFDrug CarriersinulinChemistrytumourOrganic ChemistryTransfection021001 nanoscience & nanotechnologyPEG0104 chemical sciencesNanostructuresmedicine.anatomical_structureSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoChemistry (miscellaneous)BiophysicsMCF-7 CellsMolecular Medicine0210 nano-technologymedicine.drugMolecules (Basel, Switzerland)
researchProduct

Development of different nanosystems for drugs and siRNA delivery

Cancer is one of the leading causes of death in the world. Over the past several decades, the development of engineered nanosystems for targeted drug delivery have received great attention thanks to their possibility to overcome the limitations of classical cancer chemotherapy including poor solubility, targeting incapability, nonspecific action and, consequently, systemic toxicity. In this contest, four different models of nanocarriers have been analysed and compared for their capacity to target tumour tissue and to release the therapeutic agent in a controlled way: INU-EDA-P,C-DOXO; PHEA-EDA-P,C-DOXO; PVP-siRNA and RGO-siRNA. Inulin and PHEA were conjugated to the antineoplastic drug doxo…

siRNA deliverySettore BIO/10 - BiochimicaNanosystems; tumour therapy; drug delivery; siRNA deliverydrug deliveryNanosystemtumour therapy
researchProduct

Inulin Derivatives Obtained Via Enhanced Microwave Synthesis for Nucleic Acid Based Drug Delivery

2015

A new class of therapeutic agents with a high potential for the treatment of different socially relevant human diseases is represented by Nucleic Acid Based Drugs (NABD), including small interfering RNAs (siRNA), decoy oligodeoxynucleotides (decoy ODN) and antisense oligonucleotides (ASOs). Although NABD can be engineered to be specifically directed against virtually any target, their susceptibility to nuclease degradation and the difficulty of delivery into target tissues severely limit their use in clinical practice and require the development of an appropriate nanostructured delivery system. For delivery of NABD, Inulin (Inu), a natural, water soluble and biocompatible polysaccharide, wa…

siRNA deliverymicrowavespermineSettore CHIM/09 - Farmaceutico Tecnologico Applicativopolyplexnucleic acid based drugsInulin; microwave; nucleic acid based drugs; polyplex; siRNA delivery; spermineInulinInulin microwave nucleic acid based drugs polyplex siRNA delivery spermine
researchProduct

Cationic solid lipid nanoparticles complexed with genetic material for liver tumor treatment

2015

Concept Gene therapy is a growing field of medicine with great potential for the treatment of several diseases and it is based on the delivery of nucleic acids (DNA, RNA, etc.,) to specific cells. To achieve their therapeutic effects, the nucleic acids need to cross several biological barriers and be protected from the degradation by nucleases, present in biological fluids and intracellular compartments, to successfully gain access to their intracellular targets. To overcome these hurdles, it is necessary to deliver the genetic material with biocompatible carriers able to facilitate its translocation across the cell membranes and protect it from being degraded while circulating in the blood…

siRNADNA plasmidCATIONIC NANOPARTICLEScationic nanoparticles liver gene deliveryHEPATOCARCINOMAGENE DELIVERY
researchProduct

Microneedle-Based Delivery: An Overview of Current Applications and Trends

2020

Microneedle arrays (MNA) are considered as one of the most promising resources to achieve systemic effects by transdermal delivery of drugs. They are designed as a minimally invasive, painless system which can bypass the stratum corneum, overcoming the potential drawbacks of subcutaneous injections and other transdermal delivery systems such as chemical enhancers, nano and microparticles, or physical treatments. As a trendy field in pharmaceutical and biomedical research, its applications are constantly evolving, even though they are based on very well-established techniques. The number of molecules administered by MNA are also increasing, with insulin and vaccines administration being the …

skinmicroneedlesComputer sciencePharmaceutical Sciencelcsh:RS1-441NanotechnologyReview02 engineering and technologyMicroneedle arrayStratum corneum030226 pharmacology & pharmacylcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingStratum corneummedicineTransdermal deliverystratum corneumTransdermalSkinmicroneedle arrayBuccal administration021001 nanoscience & nanotechnologymedicine.anatomical_structure/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingtransdermal delivery/dk/atira/pure/subjectarea/asjc/3000/30030210 nano-technologyMicroneedlesPharmaceutics
researchProduct

SOLID LIPID NANOPARTICLES CONTAINING AN ANTIOXIDANT COMPOUND IN ALZHEIMER’S DISEASE

2008

solid lipid nanoparticles drug delivery alzheimer's diseaseSettore CHIM/09 - Farmaceutico Tecnologico Applicativo
researchProduct

Advances in Nanoliposomes Production for Ferrous Sulfate Delivery

2020

In this study, a continuous bench scale apparatus based on microfluidic fluid dynamic principles was used in the production of ferrous sulfate-nanoliposomes for pharmaceutical/nutraceutical applications, optimizing their formulation with respect to the products already present on the market. After an evaluation of its fluid dynamic nature, the simil-microfluidic (SMF) apparatus was first used to study the effects of the adopted process parameters on vesicles dimensional features by using ultrasonic energy to enhance liposomes homogenization. Subsequently, iron-nanoliposomes were produced at different weight ratios of ferrous sulfate to the total formulation components (0.06, 0.035, 0.02, an…

sonicationMaterials sciencenanoliposomeSonicationMicrofluidicslcsh:RS1-441Pharmaceutical Sciencenanoliposome; drug delivery; ferrous sulfate; simil-microfluidic apparatus; sonication;02 engineering and technology030226 pharmacology & pharmacyHomogenization (chemistry)ArticleFerrouslcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicineLiposomeVesiclesimil-microfluidic apparatus021001 nanoscience & nanotechnologyChemical engineeringdrug deliveryDrug deliveryUltrasonic sensor0210 nano-technologyferrous sulfatePharmaceutics
researchProduct